Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Regulating oestrogen in men may lead to treatment for prostate cancer and benign prostate hyperplasia

06.11.2006
A special type of oestrogen-regulating drug may reverse the progression of prostate cancer and prostate swelling (benign prostate hyperplasia, or BHP), according to a group from Monash University, Melbourne presenting its results at the Society for Endocrinology conference in London.

Oestrogens are normally thought of as a female hormone, but recently scientists have found that oestrogens have vital roles to play in men’s health; without estrogens at all men are tall and overweight and develop diabetes. Now scientists are beginning to realise that oestrogen also has a major role to play in the development of the prostate gland and may contribute to common male problems, prostate cancer and BHP.

Prostate cancer is the most common cancer in British men, with more than 30,000 new cases diagnosed every year. 43% of British men over the age of 65 suffer from BHP.

There are two types of receptors for the hormone oestrogen, oestrogen-receptor-alpha and oestrogen receptor-beta. A group of scientists led by Professor Gail Risbridger (Monash University, Melbourne) have tested compounds that selectively activate one but not the other receptor. Thus, they can turn on one receptor eg oestrogen receptor alpha without affecting oestrogen receptor beta and vice versa.

Working in animals, they found that regulating the oestrogen receptor beta was beneficial and stopped the development of prostate hyperplasia. Whereas the bad effects of estrogens are due to activation of the oestrogen receptor alpha and are linked to malignancy.

Presenting her results at the conference in London, Professor Risbridger said

“We still have to try the drugs in humans, but so far these are very promising results. This work holds out the possibility that we may be able to help patients with benign disease as well as men with prostate cancer, by using these designer drugs.

Ideally, we would want to promote the good effects of oestrogen receptor beta and block the bad effects of oestrogen receptor alpha.

It's interesting work, and we are pleased that preclinical testing may translate into real benefits for patients”.

The work is being presented at the Society for Endocrinology conference, but it has also just been accepted for publication in the journal Endocrinology; for the abstract of the Endocrinology article, see:

http://endo.endojournals.org/cgi/content/abstract/en.2006-0906v1

Jo Thurston | alfa
Further information:
http://www.endocrinology.org
http://endo.endojournals.org/cgi/content/abstract/en.2006-0906v1

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>